Trade EYPT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
EyePoint, Inc. (EYPT) is trading at US$3.85, down 3.51% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$458.65M. Over the past 52 weeks, EYPT has traded between US$3.42 and US$19.11. On Syfe you can trade EYPT with $0 commission and add it to your watchlist.
| Previous close | US$3.99 |
|---|---|
| Market cap | US$458.65M |
| 52-week range | US$3.42 – US$19.11 |
| Volume | 7.26M |
| Exchange | US |
Add to Watchlist
Set Price Alert
EyePoint, Inc.
EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Year: 2005
EyePoint Faces Regulatory Uncertainty After Lugano Trial Miss, RBC Capital Markets Says
Aug 18, 3:09 PM · MT Newswires
Chardan Downgrades EyePoint Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $65
Aug 18, 12:14 PM · MT Newswires
RBC Downgrades EyePoint to Sector Perform From Outperform, Cuts Price Target to $5 From $37, Keeps Speculative Risk
Aug 18, 10:32 AM · MT Newswires
HC Wainwright Downgrades EyePoint Pharmaceuticals to Neutral From Buy
Aug 18, 10:28 AM · MT Newswires
EyePoint, Inc. (EYPT) stock is trading at US$3.85, -3.51% from the previous close of US$3.99.
The market cap for EyePoint, Inc. (EYPT) stock is approximately US$458.65M.
The 52-week high for EyePoint, Inc. (EYPT) stock is US$19.11.
The 52-week low for EyePoint, Inc. (EYPT) stock is US$3.42.
EyePoint, Inc. (EYPT) does not currently pay a dividend.
Stay on top of EYPT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
